Detalhe da pesquisa
1.
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challenge.
Alzheimers Dement
; 19(5): 1800-1820, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36284403
2.
A Model to Assess the Outcomes Associated With Dementia With Lewy Bodies.
Alzheimer Dis Assoc Disord
; 35(1): 68-74, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33044304
3.
Impact of sleep disturbances on employment and work productivity among midlife women in the US SWAN database: a brief report.
Menopause
; 28(10): 1176-1180, 2021 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34469936
4.
Direct Medical Costs of Dementia With Lewy Bodies by Disease Complexity.
J Am Med Dir Assoc
; 21(11): 1696-1704.e5, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32773201
5.
Cost Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in Colombia.
Pharmacoecon Open
; 4(1): 79-90, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31168754
6.
The impact of persistence with mirabegron usage vs switching to onabotulinumtoxinA on healthcare costs and resource utilization in patients with overactive bladder in the United States.
J Med Econ
; 20(12): 1272-1280, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28805473